Introduction
The actin network is composed of highly organized structures that not only determine the morphology of the cell, but also influence cellular signaling by controlling trafficking and distribution of membrane-bound proteins. In neurons, the actin network plays crucial roles in neurite differentiation, dendritic branching, spine dynamics, and synaptic transmission (Cingolani and Goda, 2008; Pak et al., 2008) . Among the various building blocks that make up the actin scaffold, filamin A (FLNa) is a protein that promotes a three-dimensional, orthogonal network organization by cross-linking filamentous actin in a perpendicular orientation (Stossel et al., 2001; Nakamura et al., 2007) . These unique crosslinking features endow FLNa with important roles in regulating cellular structure, motility and elasticity across a variety of tissues and cell types (Popowicz et al., 2006; Nakamura et al., 2011) .
In addition to its structural roles, FLNa binds to various ion channels, receptors and other signaling molecules, and thus influences their distribution, trafficking, and function. For example, FLNa facilitates surface expression of the potassium channel subtypes Kir2.1, Kv4.2 and BK Ca (Petrecca et al., 2000; Sampson et al., 2003; Kim et al., 2007b) and inhibits surface expression and function of the non-selective cationic HCN1 channel (Gravante et al., 2004) . Other roles include regulating agonist-induced internalization and G-protein binding of mu opioid receptors (Onoprishvili et al., 2003; Wang et al., 2008) and controlling the functional properties of dopamine D2 receptors and HCN1 channels (Li et al., 2000; Gravante et al., 2004) . Accumulating evidence suggests that interaction of FLNa with receptors and ion channels takes place also in the brain: FLNa was found to associate with G o -coupled mu opioid receptors and with Kv4.2 channels in the adult rat striatum and in cerebellum, respectively (Petrecca et al., 2000; Wang et al., 2008) , and HCN1 channel protein was coimmunoprecipitated with FLNa in the bovine brain (Gravante et al., 2004) . Furthermore, FLNa colocalizes with Kv4.2 channels and D2 receptors in primary neuronal cultures (Petrecca et al., 2000; Lin et al., 2001 ).
FLNa has been subject of intense research in the developing mammalian brain, where it serves critical roles in neuronal migration. Loss-of-function mutations in the FLNa gene have been strongly associated with human periventricular heterotopia (e.g. Fox et al., 1998; Sheen et al., 2005; Parrini et al., 2006) . In this disorder, aberrant FLNa hinder migration of neurons by either interfering with actin remodeling or by destabilizing the surface lining of the ventricular zone (Sarkisian et al., 2008) . In accord with its importance for brain development, FLNa is expressed in high levels in the prenatal and neonatal brain, and these levels diminish during adolescence to reach steady, moderate, expression in adulthood (Fox et al., 1998; Sheen et al., 2002) .
Whereas the presence of FLNa in the adult brain has been well documented (e.g. Fox et al., 1998; Petrecca et al., 2000; Sheen et al., 2002; Wang et al., 2008) , a systematic analysis of its expression patterns and subcellular distribution is lacking. Such characterization can be especially helpful in light of the potential roles that FLNa may serve in receptor and ion channel trafficking. In this study, we combine immunocytochemical approaches in vivo and in vitro to characterize the selective expression of FLNa in the rat brain and the subcellular localization of this actin-binding protein in mature neurons.
Experimental Procedures

Animals
Sprague-Dawley rats aged 0, 16, 90, and 120 days were used in this study. Animals were kept on a 12 hour light/dark cycle and given free access to food and water. All experiments were carried out according to NIH guidelines for the care of experimental animals, with approval by the University of California Institutional Animal Care and Use Committee (IACUC).
Antibody characterization
A list of the antibodies used in this study and their details is provided in Table 1 . Further information is provided below:
FLNa: Two FLNa antibodies, raised against either the C' or the N' terminus of the protein were used in this study. Detailed assessment of their specificity, as determined by western blot and immunocytochemistry, is provided in the Results section.
MAP2:
A monoclonal anti-microtubule-associated protein 2 (MAP2) antibody was used as a dendritic marker (clone HM-2). The antibody was made by immunizing mice against rat brain MAP2 (as stated in the manufacturer's information sheet). Western blot experiments yielded a single band that corresponded to the predicted molecular weight of MAP2 (Huber and Matus, 1984) . Immunolabeling of hippocampal neurons resulted in a typical dendritic staining pattern (Lim et al., 2008) , which was reproduced in our study (Fig. 10) .
GAD65:
A monoclonal glutamic acid decarboxylase 65 (GAD65) antibody was used as an interneuronal marker (Millipore, clone GAD6) . This antibody recognizes the lower molecular weight form of the protein (Chang and Gottlieb, 1988) . The distribution pattern of GAD65 in rat neurons has been previously described using the same antibody (e.g. Rostkowski et al., 2009) . Consistent with previous studies, the typical punctate distribution of GAD65 along GABAergic axon terminals and in interneuronal somata was observed in our hands (Fig. 9) .
PSD-95:
Post-synaptic density protein 95 (PSD-95) is an established marker for postsynaptic structures, and these are typically found on dendritic spines. The specificity of the monocolonal antibody used in our study (Clone 7E3-1B8) has been demonstrated in Western blotting (manufacturer's information sheet and Kornau et al., 1995) . A typical, punctate synaptic expression pattern and colocalization with other synaptic proteins have been described in immunolabeling studies (Lepousez et al., 2010) , and reproduced in our hands.
GluR1:
The rabbit anti-GluR1 antibody used here has been extensively characterized in both light and electron microscopy studies (e.g. King et al., 2006; Das et al., 2008) . It recognizes a single band that corresponds to the expected molecular weight of GluR1 (Wenthold et al., 1992) and shows no signal in immunoblots from GluR1 knockout animals (Zamanillo et al., 1999) .
Western blot analysis
Sprague-Dawley rats of different ages (P0, P16, P120) were used for protein analysis. Animal was decapitated and the brain was rapidly dissected and placed in pre-labeled microcentrifuge tubes residing in a container filled with dry ice and stored at -80°C until homogenization and processing. The tissue was homogenized in glass/Teflon homogenizers in cold RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 1% Triton X-100, 1 mM EDTA, 150 mM NaCl, 1× PIC). After homogenization, samples were centrifuged at 16,000× g for 5 minutes at 4°C. Protein concentration was determined using Bio-Rad Protein assay (Bio-Rad).
Protein samples (30 μg) were suspended in Laemmli buffer, separated by 4-12% SDS-PAGE and visualized using the enhanced chemiluminesence ECL-Plus kit (Amersham Pharmacia Biotech). Following SDS-PAGE, samples were transferred to PVDF membranes (Amersham Pharmacia Biotech) and nonspecific binding was blocked by incubation with 10% non-fat milk in PBS for 1 hour at room temperature. Membranes were probed with anti-FLNa or anti-actin antibodies (Table 1) in PBS with 5% non-fat milk overnight at 4°C, followed by washes in PBS containing 1% Tween (PBS-Tw) (6 × 5 minutes). Membranes were then incubated with horseradish peroxidase (HRP) conjugated anti-rabbit or mouse IgG (1:10,000, Amersham Pharmacia Biotech) in PBS for 1 hour at room temperature. After final washes in PBS-Tw (4 × 15 minutes), membranes were incubated with ECL-Plus (GE Healthcare Life Sciences) for 5 minutes and immunoreactive bands visualized by apposing membrane to hyperfilm TM ECL (GE Helathcare Life Sciences). 
Primary neuronal cultures
Dissociated primary neuronal cultures were prepared from hippocampi of postnatal day 0 (P0) rats as previously described (Noam et al., 2010) . Briefly, hippocampi were dissected and separated from adherent tissue, followed by 30 minutes incubation with 10 units per ml of the protease papain (Worthington). Papain was removed by a series of washes in decreasing concentrations of the papain inhibitor ovomucoid (Sigma-Aldrich). Cells were mechanically triturated and plated at a density of 200-400 cells/mm 2 on 12 mm glass coverslips that were pre-coated with Poly-D-Lysine (Sigma-Aldrich). At the 3 rd day in culture, 1 µM of the mitotic inhibitor cytosine arabinoside (Sigma-Aldrich) was added in order to limit glial growth. The neuronal cultures were refreshed twice a week with a pre-conditioned medium that was prepared by incubating confluent non-neuronal cultures prepared from P3-P4 rat cortices with Neurobasal Medium and B27 supplement (Invitrogen) for 24 hours. Cultures were maintained for 3-4 weeks in a humidified incubator, at 36°C and 5% CO 2 .
Immunocytochemistry (ICC) of neuronal cultures
Glass coverslips containing 3-4 weeks old neuronal cultures were washed briefly with icecold 0.01 M PBS solution, fixed in 4% paraformaldehyde for 20 minutes on ice, followed by a series of washes with PBS (5 × 5 minutes). Cells were permeabilized with 0.1% Triton-X in PBS for 10 minutes, followed by 1 hour incubation with a blocking solution (1% BSA and 5% goat serum in PBS) at room temperature. Primary antibodies were diluted in PBS containing 1% BSA, and were applied overnight at 4°C using the dilutions described in Table 1 . The following day, primary antibodies were removed by a series of washes, and a secondary antibody, Alexa Fluor 488/568 goat anti-rabbit or anti-mouse IgG (1:400, Invitrogen) was applied for 30 minutes at room temperature, protected from light. Following the removal of the secondary antibody, coverslips were washed 3 times with PBS at 5-minute intervals, and mounted on a glass coverglass using Fluoromount G mounting gel (SouthernBiotech).
Tissue preparation and ICC of brain slices P90 male rats (n = 4) were perfused via the ascending aorta with 0.9% saline solution followed by perfusion with 4% paraformaldehyde solution made in 0.1 M PB (pH 7.4, 4°C). Brains were postfixed for 3 hours (4°C) and immersed in 15%, followed by 25% sucrose for cryoprotection. Brains were blocked in the coronal or sagittal planes and sectioned at 20 μm thickness using a cryostat. In each plane, 1 in 8 serial sections were subjected to FLNa-ICC and an adjacent series of sections was stained with cresyl violet. The others were used for double labeling ICC.
FLNa-ICC was performed on free-floating sections using standard avidin-biotin complex methods, as described previously (Chen et al., 2001c) . Briefly, after several washes with PBS containing 0.3% Triton X-100 (PBS-T, pH 7.4), sections were treated with 0.3% H 2 O 2 /PBS for 30 minutes, then blocked with 5% normal goat serum (NGS) for 30 minutes in order to prevent non-specific binding. After rinsing, sections were incubated for 36 hours at 4°C with rabbit anti-FLNa antiserum (Table 1) in PBS containing 1% BSA, and washed in PBS-T (3 × 5 minutes). Sections were incubated with biotinylated goat-anti-rabbit IgG (1:400, Vector laboratories) in PBS for 2 hours at room temperature. After washing (3 × 5 minutes), sections were incubated with the avidin-biotin-peroxidase complex solution (1:100, Vector) for 3 hours, rinsed (3 × 5 minutes), and reacted with 0.04% 3,3'-diaminobenzidine (DAB) containing 0.01% H 2 O 2 .
Co-labeling of FLNa with either MAP2 or PSD-95 was performed using the tyramide signal amplification (TSA) technique (Chen et al., 2004) . Sections were incubated overnight (4°C) with FLNa rabbit antiserum (1:10,000, Santa-Cruz), then treated with HRP conjugated antirabbit IgG (1:1,000; Perkin Elmer) for 1.5 hours. Cy3-conjugated tyramide was diluted (1:150) in amplification buffer (Perkin Elmer), and was applied in the dark for 5-6 minutes. Following FLNa detection, sections were exposed to MAP2 or PSD-95 antiserum overnight at 4°C, and immunoreactivity was visualized using anti-mouse IgG conjugated to AlexaFluor 488 (1:400, Invitrogen).
Imaging and analysis
Brain sections were visualized on a Nikon Eclipse E400 epi-fluorescence microscope equipped with fluorescein, rhodamine, and DAPI/FITC/TRITC filter sets. Light microscope images were obtained using a Nikon Digital Sight camera controlled by NIS-Elements F software (version 3.0, Nikon Instruments Inc.). Confocal images were taken using an LSM-510 confocal microscope (Zeiss) with an Apochromat 63× oil objective (numeric aperture = 1.40). Virtual z-sections of <1 µm were taken at 0.2-0.5 µm intervals. Image frame was digitized at 12 bit using a 1024 × 1024 pixel frame size. To prevent signal cross-talk (bleedthrough) in dual-labeling experiments, images were scanned sequentially (using the "multi-track" mode) by two separate excitation laser beams: an Argon laser at a wavelength of 488 nm and a He/Ne laser at 543 nm. Z-stack reconstructions and final adjustments of image brightness were performed using ImageJ software (version 1.43, NIH).
Results
Specificity of FLNa antibodies
Two separate antisera directed against epitopes at either the N'-or the C'-terminus of FLNa were used (Table 1) . Both antisera recognized an approximately 280-kDa protein (Fig. 1A,B) , in good agreement with the expected molecular weight of FLNa. These antisera have been previously employed in Western blot and immunocytochemistry studies (e.g. Fox et al., 1998; Calderwood et al., 2001; Lu et al., 2006; Kim et al., 2007a; Bastian et al., 2010) , yielding specific bands at the appropriate molecular weight, which were absent in a cell line devoid of FLNa (Bachmann et al., 2006; Kim et al., 2007a; Mammoto et al., 2007) . In the case of the N'-terminus-directed antibody, additional and weaker bands were observed, particularly a ~190 KDa band which has been previously identified as a calpain cleavage product of FLNa (Aakhus et al., 1992) . Furthermore, developmental reduction in the specific 280 KDa band intensity was observed using either antibody when comparing brain extracts of different ages (Fig. 1A ,B), consistent with previous reports on the developmental regulation of FLNa protein and mRNA in the brain (Fox et al., 1998; Sheen et al., 2002) . In addition, immunocytochemical labeling of primary hippocampal neurons with either of the antibodies yielded similar distribution patterns. Control groups that were treated in identical manner to the labeled neurons but were deprived of the primary antibody had only negligible signal when compared side-by-side with their counterparts under the exact same imaging conditions (Fig. 1C-F) . Taken together, the results confirm previous work and support the specificity of both the N'-and C'-terminus FLNa antibodies used in this study. The typical decline in FLNa protein levels during brain development is shown by using animals from three age groups, as indicated (P: postnatal day). For each age group, two animals were used (represented by two separate lanes). C-F, Immunolabeling of primary hippocampal cultures (3-4 weeks in vitro) showing positive signal and similar distribution patterns for both antibodies (C,E), whereas no signal was detected when the secondary, fluorophore-conjugated antibody was applied in the absence of pre-incubation with the primary antibody (D,F). Scale bars = 20 µm.
Region-specific distribution of FLNa in the mature rat brain
FLNa-immunoreactive (FLNa-ir) neurons were widely and selectively distributed throughout the rat brain. The density and intensity of FLNa signal were region and neuron specific. Detailed comparison of four different rat brains yielded essentially identical results, with only modest variations in labeling intensity. Below we provide a detailed description of FLNa region-specific immunoreactivity.
Telencephalon (Table 2):
Olfactory bulb: In the olfactory bulb (Fig. 2) , mitral cells were intensely immunoreactive. Strongly labeled neurons were also present in the external, but not the internal plexiform layer. In addition, many FLNa-ir puncta were found in the external plexiform layer and, rarely, in the internal plexiform layer. The granular layer contained numerous FLNa-ir puncta and a few weakly labeled neuronal somata. The majority of neurons in the anterior olfactory nucleus were FLNa-positive. Within the olfactory tubercle, labeled neurons were prominent in the pyramidal layer. Scattered multipolar, intensely labeled neurons and some mediumsize, weakly labeled cells were seen in the polymorphic layer, but none were observed in the plexiform layer.
Cerebral cortex: Neocortical areas contained a large number of FLNa-ir neurons. The most intensely labeled neurons were located in the cingulate cortex and in the somatosensory area of frontoparietal cortex, followed by the motor area of frontoparietal cortex and the temporal cortices. The laminar distribution of FLNa-ir neurons was striking: in the cingulate, frontoparietal and most other neocortical regions, while FLNA-ir neurons were distributed throughout layers II-VI, maximal signal intensity was found in layers II and V, most notably in the frontoparietal cortex motor area (Fig. 2D,E) . In the entorhinal cortex, strongly labeled neurons were scattered in layers II, V, and VI, accompanied by many moderately labeled neurons. Hippocampus: FLNa-ir neurons were most prominent in the pyramidal cell layer: CA1 pyramidal cell layer was rich in moderately labeled puncta and contained several intensely labeled large neurons. The CA2 region was distinguished by intense or moderate labeling of virtually all of pyramidal neurons. In CA3, maximal intensity of FLNa immunoreactivity was found in CA3a, with a gradual decline over CA3b and a fainter signal over CA3c. Outside of the pyramidal layer, only occasional medium-sized, multipolar or fusiform FLNa-ir neurons were scattered in strata oriens, lacunosum-moleculare and radiatum (Fig. 3) . Within the dentate gyrus, granule cell somata were outlined by a fine mesh of weakly stained puncta, with occasional, strongly labeled basket-like neurons. Large, polymorphic, intensely labeled neurons were present in the hilus, while few FLNa-ir neurons were observed in the molecular layer (Fig. 3A,B) . Most subicular pyramidal neurons were intensely labeled. were weakly labeled when compared with those in CA3 area (C). Most CA3 pyramidal neurons displayed intense signal, particularly in the CA3a sub-region. Within the dentate gyrus (DG), granular cell somata were outlined by a fine mesh of weakly stained puncta, and strong labeling was found in hilar neurons (B). Asterisks demarcate the hippocampal fissure; SO, SP, SR, SL, SLM: stratum oriens, pyramidale, radiatum, lucidum, and lacunosum-moleculare, respectively; ML, molecular layer of DG; GCL, granule cell layer. Scale bars = 200 μm in A; 100 μm in B, C.
Amygdala: Large, intensely labeled neurons were widely distributed throughout the magnocellular and ventral regions of the basolateral nucleus (Fig. 4) . In the central nucleus (ACe), weakly to moderately labeled neurons were found in medial and lateral divisions (Fig.  4B) . The staining pattern of the medial nucleus consisted of weakly to moderately labeled medium-sized neurons, a pattern that was shared also by the basomedial nucleus: in both nuclei, the intensity of FLNa-ir signal was not uniform along the cell-surface (Fig. 4C) . Finally, weakly labeled neurons were present in the lateral nucleus as well as in the bed nucleus of stria terminalis (considered a part of the 'extended amygdala'), where FLNa-ir neurons were abundant in both medial and lateral areas (Fig. 4) . Basal forebrain and basal ganglia: Most neurons in the lateral septum, particularly in the ventral and intermediate regions, had intense FLNa-ir signal, whereas neurons in the medial septal nucleus were moderately labeled (Fig. 5) . The magnocellular neurons in both the horizontal and vertical limbs of the diagonal band of Broca were moderately labeled. Neurons in the striatum (caudate-putamen) were not FLNa-immunoreactive. Scattered, weakly labeled neurons were apparent in the nucleus accumbens, whereas a large population of intensely labeled neurons was encountered in the globus pallidus and the ventral pallidum (Fig. 5) . A, In the lateral septum, intense labeling was evident in the ventral (LSv) and intermediate (LSi) parts, whereas only a few neurons in the dorsal part (LSd) were moderately labeled. B, Neuronal FLNa expression was not detected in the caudate putamen (CPu), whereas some blood vessels (arrows) were strongly labeled. The framed area in B2 represents a magnified blood vessel (Scale bar = 20 μm) from the framed region in B1. C: Strongly labeled neurons are scattered in both the medial septal nucleus (MS) and vertical limb of the nucleus of the diagonal band of Broca (VDB), where most neurons are moderately labeled. D: FLNa-ir neurons in the basal ganglia, including the accumbens nucleus (Acb) and ventral striatum or pallidum (VP). Weakly labeled neurons were occasionally detected in Acb, whereas neurons in VP were intensely stained. E, Neurons in the bed nucleus of the stria terminalis (BnST) and horizontal limb of the diagonal band (HDB) are weakly and moderately labeled, respectively. LV, lateral ventricle; aca, anterior part of anterior commissure; ac, anterior commissure; cc, corpus callosum; LPO, lateral preoptic area. Scale bar = 100 μm for A-E. 
Diencephalon (Table 3):
Habenula: The medial habenula was characterized by densely immunoreactive neuropil and strongly labeled neurons (Fig. 6A,B) , whereas the lateral habenula showed scattered, moderately-labeled cells.
Thalamus: The anterior nuclear group contained abundant intensely labeled FLNa-ir neurons (in the anterodorsal and anteromedial nuclei), as well as moderately labeled ones (in the anteroventral nucleus). Most neurons in the lateral nuclear group, including the dorsal (laterodorsal, LD) and posterior nuclei were weakly labeled. In the ventral group, intensely labeled neurons were abundant in the ventrolateral, ventromedial, and ventroposterior nuclei ( Fig. 6C-E) . Numerous moderately labeled neurons were also found in the thalamic reticular nucleus. Hypothalamus: Within the paraventricular nucleus (PVN), parvocellular neurons demonstrated exceptionally intense FLNa-immunoreactivity; in contrast, few positive neurons were present in the magnocellular division (Fig. 7A,B) . Neurons in the dorsal hypothalamic area were generally strongly immunolabeled. In the ventromedial nucleus (VMH), neurons were moderately labeled in both the dorsomedial and ventrolateral parts, with scattered intensely labeled ones. FLNa-ir signal in the dorsomedial hypothalamic area was mostly weak. 
Brainstem and cerebellum (Table 4)
Strongly labeled FLNa-ir neurons were found in the pontine (Fig. 8) and medullary raphe nuclei, and in their mesencephalic counterparts. Within the reticular formation, large, intensely labeled FLNa-ir neurons were often seen in the pontine and gigantocellular reticular nuclei. Subcoeruleus was rich in moderately labeled neurons, whereas neurons in the locus coeruleus were weakly labeled (Fig. 8B) . Within trigeminal nerve nuclei, large, multipolar neurons in the motor (Fig. 8C) , principal sensory (Fig. 8B ) and spinal subnuclei were intensely FLNa immunoreactive. In the cochlear complex, the ventral nucleus had more intense labeling than the dorsal one. Some neurons in the facial, vagal, ambiguous, and hypoglossal nuclei were strongly FLNa immunoreactive (not shown). Medium-sized, intensely labeled FLNa-ir neurons were often observed in both the medial and lateral nuclei of trapezoid body. In the superior olive, medium-size FLNa-ir neurons were found (Fig. 8) .
In the cerebellum, Purkinje cells were moderately FLNa immunoreactive, whereas the granular and molecular layers contained only weakly labeled puncta (Fig. 8) . Large, multipolar neurons in the deep cerebellar nuclei were weakly stained, whereas the cerebellar white matter was devoid of FLNa immunoreactivity. Two scores are noted because the region contains cell populations with different labeling intensity.
Subcellular distribution of FLNa in vitro and in vivo
We employed mature hippocampal neurons grown in primary cultures to study the subcellular distribution of FLNa, taking advantage of the excellent amenability of these cells to optical imaging (Kaech and Banker, 2006) . To evaluate the presence of FLNa in principal and interneuronal populations in vitro, we used an antibody directed against the interneuronal marker GAD65 (Table 1) . FLNa-ir signal was detected in GAD65-negative, pyramidal neurons (Fig. 9A) , which formed the majority of neurons in culture (as previously reported;
see Benson et al., 1994; Murphy et al., 1998; Noam et al., 2010) , but was also detected in GAD65-positive neurons (Fig. 9B) , indicating that FLNa expression is not selective to one of these classes of neurons. Examination of the subcellular distribution of FLNa revealed somewhat stronger somatic FLNa-ir labeling than in dendrites. Somatic expression was characterized by punctate/clustered appearance (Fig. 10A) , and a similar punctate signal was also found along dendrites, as shown by the co-labeling of FLNa with the dendritic marker MAP2 (Fig. 10B) . In light of the actin-binding properties of FLNa and the importance of actin as a backbone of dendritic spines, we asked whether dendritic FLNa is localized to dendritic spines. To hone in on potential localization of FLNa within synapses of dendritic spines, we co-labeled FLNa with antibodies directed either against GluR1 (an ionotropic glutamate receptor localized to dendritic spines) or the post-synaptic marker PSD-95. Both procedures failed to detect significant labeling of FLNa in spines, indicating that dendritic FLNa is primarily targeted to the shaft ( Fig. 10D-F ). Having established the subcellular distribution patterns of FLNa in vitro, we examined if similar patterns occurred in vivo. We studied the distribution of FLNa in select neuronal populations of the rat brain, with the additional use of dendritic and synaptic markers. Colabeling of FLNa with the dendritic marker MAP2 revealed FLNa-positive puncta that were scattered along the dendritic shaft of layer V neocortical neurons and hippocampal (CA1 and CA3) pyramidal neurons (Fig. 11) . In line with the findings in cultured neurons, in vivo dendritic FLNa did not colocalize with PSD-95-containing puncta (Fig. 12) , and thus resided primarily in the dendritic shaft. In panels A and B, dual labeling of FLNa (green) and the dendritic marker microtubule-associated protein 2 (MAP2, red) revealed that most FLNa-ir puncta reside on the perimeter of dendrites of pyramidal neurons (arrows). FLNa was also rich in the somata of pyramidal neurons, possessing similar characteristics as observed in vitro (Fig. 10) . Framed areas in A1 and B1 were merged and magnified in the right panels A2 and B2, respectively (scale bar = 10 μm). In the CA3 area (C), the primary dendrites of pyramidal neurons were cut off on the coronal section with a brush-like shape, revealing the perimembranous distribution of the FLNa-ir puncta (arrows). The virtual slice thickness of all images is 0.5 μm. Scale bars = 20 μm in A1 and B1, 10 μm in C. . FLNa-ir puncta were frequently detected on the dendritic shaft (as also shown in Fig. 11 ), but not on the postsynaptic density. Frames denote areas magnified in the right panels. Optical slice thickness was 0.2 μm. Scale bars = 20 μm in A1, 10 μm in B1, and 5 μm in A2 and B2.
Discussion
In this study, we employed immunocytochemical techniques to characterize the expression and subcellular distribution of the actin-binding protein FLNa in mature brain and cultured neurons. We report that (1) In the mature rat brain, FLNa is expressed across wide range of regions; (2) The distribution of FLNa is selective, as demonstrated by varying degrees of immunoreactive density and intensity across distinct neuronal populations; (3) FLNa is present in somata and along the dendrites of select neuronal populations; (4) Both in vivo and in vitro, dendritic FLNa-ir signal is distributed in puncta along the shaft, while it is hardly detected in spines.
The expression and function of FLNa has been extensively studied during early brain developmental stages, when FLNa plays important roles in neuronal migration (Feng and Walsh, 2004; Sarkisian et al., 2008) . Indeed, high levels of brain FLNa are expressed in the pre-and peri-natal period throughout the cerebral cortex and particularly within migrating neurons (Sheen et al., 2002) . Although mRNA and protein levels of FLNa are downregulated during development (Sheen et al., 2002) , moderate levels of FLNa have been consistently observed in adult brain (Fox et al., 1998; Petrecca et al., 2000; Sheen et al., 2002; Wang et al., 2008) . Little is known on the precise roles of FLNa in mature neurons. By providing a comprehensive characterization of FLNa distribution across brain regions and in subcellular compartments, our data may reveal new leads to the potential functions of FLNa throughout life, including interaction with the actin transport machinery to facilitate localization of specific neuronal molecules. For example, both mu-opioid and D2/D3 dopamine receptors are highly expressed in basal forebrain structures (Arvidsson et al., 1995; Mansour et al., 1995; Khan et al., 1998; Gurevich and Joyce, 1999; Seeman et al., 2006) , and in both cases, the expression is influenced by FLNa. Recently, interaction of FLNa with mu-opioid receptors has been found to regulate G-protein binding of the receptor in the rat striatum (Wang et al., 2008) . Indeed, our findings indicate strong FLNa-ir signal in lateral septum, ventral striatum and ventral pallidum, areas where mu-opioid receptors are expressed in high levels (Mansour et al., 1995) . However, whereas mu-opioid receptors are also abundant in the caudate-putamen, we could not detect FLNa-ir neurons in this region. These differences in distribution raise the intriguing possibility of region-specific regulation of mu-opioid receptors by FLNa, which may be linked to altered function. A second molecular candidate to interact with FLNa in the mature CNS is dopamine receptors. Whereas both D2 and D3 dopamine receptors have been shown to interact with FLNa in cultured cell lines (Li et al., 2000; Lin et al., 2001) , their interaction with FLNa in the brain (and the consequences of such interaction) remain to be explored. Interestingly, the expression of FLNa in striatal regions (Fig. 5) correlates with reported levels of D3 receptor expression: intense FLNa-ir signal was found in the ventral striatum, an area that contains relatively high levels of D3 dopamine receptors (Khan et al., 1998; Seeman et al., 2006) , while no FLNa-ir was detected in the caudate-putamen region which contains D2, but not D3 receptors (Levey et al., 1993; Seeman et al., 2006) .
Both in vitro and in vivo, FLNa-ir was detected primarily in somata and along the apical dendritic shaft, but was absent from spines. Dendritic spines are specialized compartments with a backbone of polymerized actin. The interaction of actin with a number of cellular proteins and enzymes is crucial to changes in spine shape and size, and intrinsic process of synaptic plasticity (Cingolani and Goda, 2008; Hotulainen and Hoogenraad, 2010) . More specifically, a number of actin-crosslinking proteins regulate spine morphology, which is typically characterized by partially bundled actin in the spine neck and branched actin network in the spine head (Hotulainen and Hoogenraad, 2010) . There is also evidence for different properties of the cytoskeleton within dendritic spines as compared to the shaft (Hotulainen and Hoogenraad, 2010) . In the context of this paper, high FLNa concentrations promote stabilization and reduced dynamics of actin networks compared to actin networks that contain non-FLNa actin-crosslinking proteins (Tseng et al., 2004) . The exclusion of FLNa from spines, as we show here, is then logical: it enables the actin dynamics required for the changes of spine shape and size during processes of learning and memory (Chen et al., 2007) . In contrast, the presence of FLNa in the shaft may contribute to actin stability.
Additional roles of FLNa in the dendritic shaft are supported by evidence for its interaction with several dendritic ion channels such as the potassium Kv4.2 (Petrecca et al., 2000) , inward rectifying Kir2.1 (Sampson et al., 2003) , and the non-selective hyperpolarizationactivated HCN1 channel (Gravante et al., 2004) . In all three types of ion channels, FLNa induced clustered appearance of the channel on the cell surface, which was abolished in cells deficient in FLNa. However, whereas FLNa promotes the surface expression of Kir2.1 and Kv4.2 channels (Petrecca et al., 2000; Sampson et al., 2003) , it seems to exert an opposite, inhibitory effect on HCN1 channels (Gravante et al., 2004) . Future studies are required to determine if FLNa directly regulates surface expression of these channels in neurons. FLNa might also play a role in the co-regulation of different ion channels within the same dendrite.
Both in vivo and in vitro preparations were used in this work. In vitro systems such as the primary hippocampal neurons are inherently reduced and therefore cannot recapitulate the full properties of the living brain. However, primary neuronal cultures have been extremely beneficial for the basic study of neuronal processes: direct access for manipulation and good optical conditions made the primary hippocampal system widely popular in neuroscience research (Kaech and Banker, 2006 ). Our results demonstrate that the expression and subcellular distribution of FLNa in primary hippocampal neurons are comparable to those found in vivo, making this system adequate for future studies.
In summary, this study provides a detailed description of FLNa expression in the adult rat brain and in mature hippocampal neurons. The selective patterns found across brain regions and in distinct subcellular domains may provide important clues and several leads for future research on the roles of this actin-binding protein in regulating the structure and function of the mature brain.
